title: [A triple combination therapy of simeprevir (SM), pegylated-interferon and ribavirin (PR) with chronic hepatitis C virus genotype 1 infection].
authors: Shoko
authors: S
authors: Suzuki
authors: Masayuki
authors: M
authors: Kurosaki
authors: Namiki
authors: N
authors: Izumi
mesh_terms: D004338:Drug Combinations; D024882:Drug Resistance, Viral; D005838:Genotype; D016174:Hepacivirus / Q000187:drug effects* / Q000235:genetics; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000009:adverse effects / Q000627:therapeutic use*; D007378:Interleukins / Q000235:genetics; D012254:Ribavirin / Q000009:adverse effects / Q000627:therapeutic use*; D000069616:Simeprevir / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*; D000095022:Interferon Lambda
chemical_list: D004338:Drug Combinations; D007372:Interferons; D007378:Interleukins; D012254:Ribavirin; D000069616:Simeprevir; C000624353:interferon-lambda, human; D000095022:Interferon Lambda